ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Clinical trial NCT00839826 · COMPLETED

Trial details

NCT number: NCT00839826
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thromboembolism Prevention

Start date: 2002-12-01
Primary completion: 2003-11-01
Enrollment: 641

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.